Chiral aryloxyalkylamines: Selective 5-HT(1B/1D) activation and analgesic activity. 2010

Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
Dipartimento Farmaco-Chimico, Università degli Studi di Bari, Italy. glentini@farmchim.uniba.it <glentini@farmchim.uniba.it>

A series of chiral 2,3-dichlorophenoxy and 1-naphthyloxy alkylamines were synthesized, and their binding affinities towards 5-HT(1D) and h5-HT(1B) receptors were evaluated. In the naphthyloxy series, the (R)-prolinol derivative was the most selective 5-HT(1D) ligand, while (S)-N-methyl-2-(1-naphthyloxy)propan-1-amine showed the highest selectivity for h5-HT(1B). Both compounds performed as 5-HT(1D) agonists in the isolated guinea pig assay and showed higher analgesic activity than both sumatriptan and the achiral analogue 20 b in the mouse hot-plate test. Neither ligand displayed any affinity for nicotinic ACh receptors present in mouse brain membranes, thus indicating that their analgesic activity does not arise through interaction with these receptors.

UI MeSH Term Description Entries
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D014363 Tryptamines Decarboxylated monoamine derivatives of TRYPTOPHAN. Indolylethylamines,Triptan,Triptans
D044302 Receptor, Serotonin, 5-HT1B A serotonin receptor subtype found at high levels in the BASAL GANGLIA and the frontal cortex. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1D RECEPTOR. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug's antimigraine effect. Serotonin 1B Receptor,5-HT(1B) Receptor,5-HT(1Dbeta) Receptor,5-HT1B Receptor,5-HT1Dbeta Receptor,5-Hydroxytryptamine 1B Receptor,5-Hydroxytryptamine 1B Receptors,Receptor, 5-Hydroxytryptamine 1B,Receptor, Serotonin Type 1Dbeta,Serotonin 1D Beta Receptor,Serotonin 1Dbeta Receptor,Serotonin 1Dbeta Receptors,1B Receptor, 5-Hydroxytryptamine,1B Receptors, 5-Hydroxytryptamine,5 HT1B Receptor,5 HT1Dbeta Receptor,5 Hydroxytryptamine 1B Receptor,5 Hydroxytryptamine 1B Receptors,Receptor, 5 Hydroxytryptamine 1B,Receptor, 5-HT1B,Receptor, 5-HT1Dbeta,Receptor, Serotonin 1B,Receptor, Serotonin 1Dbeta,Receptors, 5-Hydroxytryptamine 1B,Receptors, Serotonin 1Dbeta
D044346 Receptor, Serotonin, 5-HT1D A serotonin receptor subtype that is localized to the CAUDATE NUCLEUS; PUTAMEN; the NUCLEUS ACCUMBENS; the HIPPOCAMPUS, and the RAPHE NUCLEI. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1B RECEPTOR, but is expressed at low levels. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug's antimigrane effect. Serotonin 1D Receptor,5-HT(1D) Receptor,5-HT(1Dalpha) Receptor,5-HT1D Receptor,5-HT1Dalpha Receptor,5-Hydroxytryptamine1D Receptor,Receptor, Serotonin 1D,Receptor, Serotonin 1Dalpha,Serotonin 1D Alpha Receptor,Serotonin 1D Receptors,Serotonin 1Dalpha Receptor,Serotonin 1Dalpha Receptors,5 HT1D Receptor,5 Hydroxytryptamine1D Receptor,Receptor, 5-HT1D,Receptor, 5-Hydroxytryptamine1D,Receptors, Serotonin 1D
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D058825 Serotonin 5-HT1 Receptor Agonists Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. 5-HT1 Agonists,5-HT1 Agonist,5-HT1A Agonist,5-HT1B Agonist,5-HT1B-D Agonist,5-HT1D Agonist,Serotonin 5-HT1A Receptor Agonists,Serotonin 5-HT1B Receptor Agonists,Serotonin 5-HT1B-D Agonists,Serotonin 5-HT1D Receptor Agonists,5 HT1 Agonist,5 HT1 Agonists,5 HT1A Agonist,5 HT1B Agonist,5 HT1B D Agonist,5 HT1D Agonist,5-HT1B-D Agonists, Serotonin,Agonist, 5-HT1,Agonist, 5-HT1A,Agonist, 5-HT1B,Agonist, 5-HT1B-D,Agonist, 5-HT1D,Agonists, 5-HT1,Agonists, Serotonin 5-HT1B-D,Serotonin 5 HT1 Receptor Agonists,Serotonin 5 HT1A Receptor Agonists,Serotonin 5 HT1B D Agonists,Serotonin 5 HT1B Receptor Agonists,Serotonin 5 HT1D Receptor Agonists

Related Publications

Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
April 2002, Headache,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
July 2001, British journal of pharmacology,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
October 2008, Bioorganic & medicinal chemistry letters,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
March 2000, Journal of medicinal chemistry,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
September 2004, Annals of neurology,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
March 2001, Headache,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
June 2006, Headache,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
June 2001, Neuroreport,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
December 2001, Circulation research,
Alessia Carocci, and Giovanni Lentini, and Alessia Catalano, and Maria Maddalena Cavalluzzi, and Claudio Bruno, and Marilena Muraglia, and Nicola Antonio Colabufo, and Nicoletta Galeotti, and Filomena Corbo, and Rosanna Matucci, and Carla Ghelardini, and Carlo Franchini
March 2003, British journal of pharmacology,
Copied contents to your clipboard!